Riskpilot← Back to searchSign inGet full accessMediq Sverige AB
ABActiveOrg 5562522317Hallabäcksvägen 1Wholesale of pharmaceutical and medical goods · NACE 4646Est. 1985192 employees
Revenue 2024
SEK 1,3B
0% vs 2023
EBITDA margin
-6.3%
-4% vs 2023
Equity ratio
43.3%
Financial strength
Net profit 2024
SEK -85,3M
+32% vs 2023
| Revenue | SEK 1,3B | +0% |
| EBITDA | SEK -81,2M | -4% |
| Net profit | SEK -85,3M | +32% |
| Total assets | SEK 418M | -5% |
| Equity | SEK 181,1M | +33% |
| Employees | 192 | — |
Legal name
Mediq Sverige AB
Org number
5562522317
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
15 januari 1985
Share capital
SEK 1 100 000
Employees
192 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget skall idka handel med produkter och material för hälso och sjukvårdsbranschen samt annan därmed förenlig verksamhet. Dessutom får bolaget äga sådan fast egendom som utnyttjas i verksamheten.
Address
Hallabäcksvägen 1
Phone
+46313889000
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 122 971 | 1 116 736 | 1 118 972 | 1 293 380 | 1 287 324 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 21 939 | −6 285 | −45 915 | −78 265 | −81 217 |
| Depreciation & amort. | — | — | — | — | — |
| EBIT | 21 939 | −6 285 | −45 915 | −78 265 | −81 217 |
| Net financials | −11 986 | 5 034 | 17 673 | −27 129 | −4 034 |
| Profit before tax | 9 953 | −1 251 | −28 242 | −105 394 | −85 251 |
| Tax | 496 | 16 661 | 6 688 | −20 528 | −0 |
| Net profit | 10 449 | 15 410 | −21 554 | −125 922 | −85 251 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 371 855 | 364 916 | 409 237 | 438 585 | 418 032 |
| Equity | 152 372 | 167 782 | 146 228 | 136 306 | 181 056 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 207 775 | 186 357 | 250 449 | 288 193 | 221 895 |
| Total debt | 207 775 | 186 357 | 250 449 | 288 193 | 221 895 |
EBITDA margin
-6.3%
This company
15.8%
Market median
-140% vs market
20202024
Equity ratio
43.3%
This company
38.2%
Market median
+13% vs market
20202024
Return on equity
-47.1%
This company
18.4%
Market median
-356% vs market
20202024
Net profit margin
-6.6%
This company
8.1%
Market median
-181% vs market
20202024
Asset turnover
3.08×
This company
1.12×
Market median
+175% vs market
20202024
Debt / equity
1.31×
This company
0.62×
Market median
-111% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
FD Chief Auditor | Chief Auditor | 2020 |
| Former (8) | ||
MJ External Signatory | External Signatory | 2020 – 2022 |
GK Chief Executive Officer | Chief Executive Officer | 2020 – 2022 |
TL External Signatory | External Signatory | 2022 – 2023 |
SA Chief Executive Officer | Chief Executive Officer | 2022 – 2022 |
PA External Signatory | External Signatory | 2020 – 2022 |
KJ Chief Auditor | Chief Auditor | 2022 – 2023 |
OS External Signatory | External Signatory | 2020 – 2022 |
CK Chief Executive Officer | Chief Executive Officer | 2022 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Chairman | 2020 | |
| Deputy Board Member | 2020 | |
| Board of Directors | 2025 | |
| Board of Directors | 2022 | |
| Former (3) | ||
| Board of Directors | 2020 – 2025 | |
| Deputy Board Member | 2022 – 2023 | |
| Board of Directors | 2020 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Mediq Holding Sverige AB
Mediq Sverige AB Board members of Mediq Sverige AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mats Johan Torbjörn Markgren | External Signatory | 0 companies |
| Gunilla Kristina Rittgård | Chief Executive Officer | 0 companies |
| Therje Lage Johansen | External Signatory | 0 companies |
| Shahram Abelsson Khorsand | Chief Executive Officer | 0 companies |
| Pasi Antero Hotinen | External Signatory | 0 companies |
| Karl Johan Kratz | Chief Auditor | 0 companies |
| Filip David Larsson | Chief Auditor | 0 companies |
| Oscar Sebastian Molin | External Signatory | 0 companies |
| Christian Kanstrup | Chief Executive Officer | 0 companies |
| Joachim Warnberg | Chairman | 0 companies |
| Christa Elisabeth Volmer Nielsen | Deputy Board Member | 0 companies |
| Thorbjørn Hjarndal | Board of Directors | 0 companies |
| Rogier Dirk Anton Stap | Board of Directors | 0 companies |
| Philip Mørch Nadelmann | Board of Directors | 0 companies |
| Jan Henning Albrechtsen | Deputy Board Member | 0 companies |
| Pernilla Maria Westin | Board of Directors | 0 companies |